CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Acadia Pharmaceuticals Inc  (ACAD)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

ACAD's Revenue Year on Year Growth by Quarter and Year

Acadia Pharmaceuticals Inc's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
ACAD Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 17.19 0.04 0.02
III Quarter September - 0.10 - 0.03
II Quarter June 30.48 - - 0.03
I Quarter March 15.29 0.02 0.05 -3.02
FY   45.77 17.31 0.09 -2.94

Financial Statements
Acadia Pharmaceuticals Inc's second quarter 2017 Revenue $ 30.48 millions ACAD's Income Statement
Acadia Pharmaceuticals Inc's second quarter 2016 Revenue $ 0.00 millions Quarterly ACAD's Income Statement
ACAD's Growth by Division See ACAD's Growth by Segment

ACAD Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 42875 % 100 % -91.67 %
III Quarter September - - - -93.33 %
II Quarter June - - - -92.11 %
I Quarter March 76350 % -60 % - -
FY   - 19133.33 % - -



ACAD Revenue Growth Comment
Acadia Pharmaceuticals Inc in the second quarter achieved Revenue of $ 30.48 millions compare to recorded in same quarter a year ago.

According to the results reported in the second quarter, Acadia Pharmaceuticals Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Acadia Pharmaceuticals Inc' s Revenue no change of % ranks overall at the positon no. 14 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #4
Overall #14
Revenue Y/Y Growth Statistics
High Average Low
382050 % 40276.83 % -96.43 %
(Mar 31 2017)   (Jun 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ACAD's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ACAD's Competitors
Revenue Growth for Acadia Pharmaceuticals Inc's Suppliers
Revenue Growth for ACAD's Customers

You may also want to know
ACAD's Annual Growth Rates ACAD's Profitability Ratios ACAD's Asset Turnover Ratio ACAD's Dividend Growth
ACAD's Roe ACAD's Valuation Ratios ACAD's Financial Strength Ratios ACAD's Dividend Payout Ratio
ACAD's Roa ACAD's Inventory Turnover Ratio ACAD's Growth Rates ACAD's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Fate Therapeutics Inc -0.10 %$ -0.097 millions
Psychemedics Corp -0.17 %$ -0.165 millions
Halyard Health, Inc. -0.20 %$ -0.200 millions
Xtant Medical Holdings, Inc. -0.25 %$ -0.249 millions
Ocular Therapeutix, Inc. -0.68 %$ -0.680 millions
Emergent Biosolutions Inc. -0.70 %$ -0.705 millions
Tenet Healthcare Corp -0.90 %$ -0.900 millions
Integrated Biopharma Inc -1.21 %$ -1.212 millions
Genmark Diagnostics, Inc. -1.22 %$ -1.223 millions
Trovagene, Inc. -1.34 %$ -1.343 millions
Mymetics Corp -1.86 %$ -1.858 millions
Vaso Corp -1.98 %$ -1.982 millions
Recro Pharma, Inc. -2.00 %$ -1.997 millions
Inc Research Holdings, Inc. -2.13 %$ -2.130 millions
Quorum Health Corporation -2.16 %$ -2.165 millions
China Biologic Products Holdings, Inc. -2.34 %$ -2.344 millions
Msa Safety Incorporated -2.44 %$ -2.440 millions
Pacific Biosciences Of California, Inc. -3.25 %$ -3.249 millions
T2 Biosystems, Inc. -3.43 %$ -3.434 millions
Therapeuticsmd, Inc. -3.47 %$ -3.470 millions
Harvard Bioscience Inc -3.53 %$ -3.532 millions
Twinlab Consolidated Holdings, Inc. -3.61 %$ -3.614 millions
Acceleron Pharma Inc -4.32 %$ -4.319 millions
Conformis Inc -4.39 %$ -4.391 millions
Lifevantage Corp -4.51 %$ -4.510 millions
Endologix Inc -4.74 %$ -4.744 millions
Steris Plc -4.76 %$ -4.764 millions
China Senior Living Industry International Holding -4.88 %$ -4.883 millions
Becton Dickinson & Co -5.10 %$ -5.097 millions
Cancer Genetics, Inc -5.67 %$ -5.671 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GPRI's Profile

Stock Price

GPRI's Financials

GPRI's Expectations

Business Description

Fundamentals

Charts & Quotes

GPRI's News

Suppliers

GPRI's Competitors

Customers & Markets

Economic Indicators

GPRI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com